Treatment of Gingival Recessions with Connective Tissue or Concentrated Growth Factor Membrane Using Tunnel Technique
Launched by BULENT ECEVIT UNIVERSITY · Sep 20, 2020
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
The study included 108 defects in 40 patients with Miller Class I and II gingival recession. Gingival recession defects were randomly divided into two groups. Tunnel technique + connective tissue graft was applied to 20 patients in the control group (51 defects) and tunnel technique + concentrated growth factor membrane was applied to 20 patients in the test group (57 defects). The results at baseline and 6 months were evaluated for the following clinical parameters: Mean root coverage, complete root coverage, probing depth, clinical attachment level, gingival recession depth, gingival rece...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥18 years
- • periodontally and systemically healthy
- • presence of Miller I or II class gingival recession defect in at least two teeth on the buccal aspect of incisors, canine and premolar teeth (≥ 2 mm in depth)
- • gingival thickness ≥ 0.8 mm 2 mm apical to the gingival margin
- • presence of identifiable cementoenamel junction (CEJ) (step ≤1 mm at the CEJ level and/or presence of a root irregularity/abrasion with identifiable CEJ was accepted
- • full-mouth plaque score (FMPS) ≤20%.
- Exclusion Criteria:
- • smoking
- • contraindications for surgical periodontal treatment
- • presence of recession defects associated caries, restoration and furcation problems
- • use of systemic antibiotics for any reason in the last 3 months.
About Bulent Ecevit University
Bülent Ecevit University is a distinguished academic institution located in Zonguldak, Turkey, committed to advancing medical research and innovation. As a clinical trial sponsor, the university leverages its robust academic resources and interdisciplinary expertise to conduct high-quality research aimed at improving patient care and healthcare outcomes. The institution fosters collaboration among researchers, clinicians, and industry partners, ensuring adherence to ethical standards and regulatory compliance while promoting the translation of scientific discoveries into practical applications. Through its clinical trials, Bülent Ecevit University strives to contribute valuable insights to the medical community and enhance the overall health landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zonguldak, , Turkey
Patients applied
Trial Officials
Birsen KORKMAZ, assis. Prof.
Principal Investigator
birsenkorkmaz91@gmail.com
Umut BALLI, Assoc. Prof.
Study Director
ZBEU.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials